R. Oldenburg

发表

4.1. CHARACTERIZATION OF FAMILIAL NON-BRCA1/2 BREAST TUMORS BY LOSS OF HETEROZYGOSIT Y AND IMMUNOPHENOT YPING

P. Devilee, H. Meijers-Heijboer, H. Morreau, 2008 .

A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients

P. Devilee, L. Wessels, S. Verhoef, 2011, Breast Cancer Research and Treatment.

Only about 25% of familial breast cancer is explained by mutations in brca1 and brca2, fewer by moderate penetrance genes like p53, pten, chek2, atm and palb2 and an unknown fraction by common variants of genes with low penetrance

P. Devilee, H. Meijers-Heijboer, L. Wessels, 2008 .

Genome-wide scanning for linkage in 56 Dutch breast cancer families selected for a minimal probability of being due to BRCA1 or BRCA2

P. Devilee, H. Meijers-Heijboer, N. Hoogerbrugge, 2005, Breast Cancer Research.

UvA-DARE ( Digital Academic Repository ) A method to assess the clinical significance of unclassified variants in the BRCA 1 and BRCA 2 genes based on cancer family history

P. Devilee, A. Ouweland, M. Blok, 2009 .